H. Kaufmann

2.4k total citations
71 papers, 1.7k citations indexed

About

H. Kaufmann is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, H. Kaufmann has authored 71 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 28 papers in Molecular Biology and 16 papers in Pathology and Forensic Medicine. Recurrent topics in H. Kaufmann's work include Multiple Myeloma Research and Treatments (31 papers), Lymphoma Diagnosis and Treatment (12 papers) and Glycosylation and Glycoproteins Research (10 papers). H. Kaufmann is often cited by papers focused on Multiple Myeloma Research and Treatments (31 papers), Lymphoma Diagnosis and Treatment (12 papers) and Glycosylation and Glycoproteins Research (10 papers). H. Kaufmann collaborates with scholars based in Austria, Germany and Switzerland. H. Kaufmann's co-authors include Johannes Drach, Jutta Ackermann, H. Huber, Sonja Seidl, Christoph Zielinski, Bruno Gottstein, Niklas Zojer, Heinz Gisslinger, Andrew Hemphill and Heinz Ludwig and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

H. Kaufmann

69 papers receiving 1.6k citations

Peers

Countries citing papers authored by H. Kaufmann

Since Specialization

Citations

This map shows the geographic impact of H. Kaufmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kaufmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kaufmann more than expected).

Fields of papers citing papers by H. Kaufmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Kaufmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kaufmann. The network helps show where H. Kaufmann may publish in the future.

Co-authorship network of co-authors of H. Kaufmann

This figure shows the co-authorship network connecting the top 25 collaborators of H. Kaufmann. A scholar is included among the top collaborators of H. Kaufmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Kaufmann. H. Kaufmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	T-Cell Large Granular Lymphocyte Leukemia: An Interdisciplinary Issue? 2022 ·Frontiers in Oncology ·(unknown), Alexander Pichler, Christoph Kornauth, H. Kaufmann, Philipp B. Staber, Georg Hopfinger	1
2	SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria 2022 ·Wiener klinische Wochenschrift ·J.M. Berger, (unknown), Oliver Königsbrügge, Hanna A. Knaus, Edit Porpaczy, H. Kaufmann, (unknown), (unknown), Thomas Winder, (unknown), Dominik Wolf‎, Verena Petzer, Van Anh Nguyen, Georg Weinlich, Leopold Öhler, Anna Wonnerth, (unknown), (unknown), Matthias Preusser, Anna S. Berghoff	1
3	Cytogenetic patterns in multiple myeloma after a phase of preceding MGUS 2007 ·European Journal of Clinical Investigation ·H. Kaufmann, J Ackermann, (unknown), Verena Sagaster, Thomas Nösslinger, Michael Pfeilstöcker, Andrea Keck, Heinz Ludwig, Heinz Gisslinger, Johannes Drach	3
4	Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH) 2004 ·British Journal of Cancer ·Michael Fiegl, (unknown), Margot Haun, Wolfgang Sturm, H. Kaufmann, (unknown), Jens Krugmann, Thomas Szekeres, K Grünewald, Günther Gastl	28
5	DNA‐methylation analysis identifies the E‐cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies 2004 ·Cancer ·Sonja Seidl, Jutta Ackermann, H. Kaufmann, Andrea Keck, Thomas Nösslinger, Christoph Zielinski, Johannes Drach, Sabine Zöchbauer‐Müller	56
6	Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma 2004 ·Leukemia ·H. Kaufmann, J Ackermann, (unknown), Thomas Nösslinger, Rotraud Wieser, Sonja Seidl, Verena Sagaster, Heinz Gisslinger, Ulrich Jäger, Michael Pfeilstöcker, Christoph Zielinski, Johannes Drach	59
7	Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma 2003 ·European Journal Of Haematology ·H. Kaufmann, Elisabeth Krömer, Thomas Nösslinger, Ansgar Weltermann, Jutta Ackermann, (unknown), (unknown), Johannes Drach	24
8	Long‐term follow up of patients with multiple myeloma after high‐dose chemotherapy and allogeneic stem cell transplantation 2003 ·European Journal Of Haematology ·Werner Rabitsch, Erika Prinz, Jutta Ackermann, Stefan Wöhrer, H. Kaufmann, Sonja Seidl, Felix Keil, Peter Kalhs, Hildegard Greinix, Heinz Gisslinger, Gerda Leitner, Johannes Drach	6
9	New developments and treatment in multiple myeloma: new insights on molecular biology 2002 ·Annals of Oncology ·Johannes Drach, H. Kaufmann	6
10	Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma 2001 ·Annals of Hematology ·Nina Worel, Hildegard Greinix, J Ackermann, H. Kaufmann, (unknown), (unknown), Heinz Gisslinger, Klaus Lechner, Peter Kalhs, Johannes Drach	23
11	Advances in the biology and therapeutic management of multiple myeloma 2001 ·Annals of Hematology ·H. Kaufmann, (unknown), J Ackermann, H Huber, Johannes Drach	13
12	Aneuploidy of chromosome 7 can be detected in invasive lung cancer and associated premalignant lesions of the lung by fluorescence in situ hybridisation 2000 ·Lung Cancer ·(unknown), Gerhard Dekan, Jutta Ackermann, Michael Fiegl, H. Kaufmann, Johannes Drach, H. Huber	28
13	Binokulare dreidimensionale Videookulographie 2000 ·Der Ophthalmologe ·(unknown), H. Kaufmann	2
14	Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma. 1999 ·PubMed ·Martin Filipits, Johannes Drach, Gudrun Pohl, J. C. Schuster, Thomas Stranzl, J Ackermann, Robert Königsberg, H. Kaufmann, (unknown), H. Huber, H. Ludwig, Robert Pirker	39
15	Prise en compte de l'influence de la distribution des contraintes et des effets d'echelle pour une utilisation pratique en fatigue 1999 ·Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) ·Thierry Palin‐Luc, H. Kaufmann, (unknown), (unknown)	1
16	Hyperdiploidy and apparent aneusomy in mesothelial cells from non-malignant effusions as detected by fluorescence in situ hybridization (FISH) 1999 ·Cytometry ·Michael Fiegl, Niklas Zojer, H. Kaufmann, (unknown), (unknown), H. Huber, Johannes Drach	7
17	Adhesion and invasion of bovine endothelial cells byNeospora caninum 1996 ·Parasitology ·Andrew Hemphill, Bruno Gottstein, H. Kaufmann	116
18	Discrimination ofNeospora caninumfromToxoplasma gondiiand other apicomplexan parasites by hybridization and PCR 1996 ·Molecular and Cellular Probes ·H. Kaufmann, Mat Yamage, Isabel Roditi, D. Dobbelaere, J. P. Dubey, (unknown), A. J. Trees, Bruno Gottstein	61
19	DNA probes for the detection of Fasciola hepatica in snails 1993 ·Molecular and Cellular Probes ·Volker T. Heussler, H. Kaufmann, (unknown), Jorge S. Liz, D. Dobbelaere	22
20	[Experiences with the gamma teletherapy of the laryngeal and hypopharyngeal carcinomas]. 1967 ·PubMed ·H. Kaufmann, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact